4.8 Article

Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

A high salt diet protects interleukin 10-deficient mice against chronic colitis by improving the mucosal barrier function

Dezhi Wang et al.

Summary: A high salt diet is often linked to various diseases, and this study found that in mice lacking the IL-10 gene, a high salt diet improved colitis symptoms and increased intestinal barrier integrity. Additionally, findings from cell experiments suggested that in an inflammatory and high salt environment, IL-10 may promote inflammation by disrupting the colonic epithelial barrier.

MOLECULAR IMMUNOLOGY (2022)

Review Immunology

Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson

Paulina Krawiec et al.

Summary: Inflammatory bowel disease (IBD) presents differently in children compared to adults, with early-onset IBD associated with single genetic mutations and older children and adolescents having polygenic interactions. Identifying defects in the Il-10 pathway can lead to early recognition and management of IBD in children.

JOURNAL OF INFLAMMATION-LONDON (2021)

Review Immunology

Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review

Na Wu et al.

Summary: APLAID is a rare autoinflammatory disease caused by mutations in the PLCG2 gene. This study reported a case of APLAID patient with gangrenous pyoderma and high IgE levels, carrying a novel PLCG2 mutation, which expanded the clinical phenotype and genotype of APLAID.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration

Jacob T. Jackson et al.

Summary: PLC gamma 2 is a crucial signaling molecule downstream from cell surface receptors, its dysfunction associated with various diseases. Variants in PLC gamma 2 exhibit diverse pathologies, offering potential for therapeutic manipulation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Immunology

Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

Andrea Martin-Nalda et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2020)

Article Immunology

Single-cell landscape of immunological responses in patients with COVID-19

Ji-Yuan Zhang et al.

NATURE IMMUNOLOGY (2020)

Review Immunology

Periodic fever syndromes and the autoinflammatory diseases (AIDs)

Achille Marino et al.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)

Review Immunology

Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection

Enrique Martin-Gayo et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Immunology

Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa

Joao Farela Neves et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development

Mei Yu et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

I-TASSER server: new development for protein structure and function predictions

Jianyi Yang et al.

NUCLEIC ACIDS RESEARCH (2015)

Letter Biochemical Research Methods

MutationTaster2: mutation prediction for the deep-sequencing age

Jana Marie Schwarz et al.

NATURE METHODS (2014)

Letter Biochemical Research Methods

A method and server for predicting damaging missense mutations

Ivan A. Adzhubei et al.

NATURE METHODS (2010)

Review Immunology

Mouse and human dendritic cell subtypes

K Shortman et al.

NATURE REVIEWS IMMUNOLOGY (2002)